HB 3834
  • Introduced
    Feb 02, 2026
  • Passed House
    Mar 11, 2026
  • Passed Senate
  • Became Law
HB 3834
Oklahoma House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; Office of the State Treasurer; adverse licensing action; effective date.
Last Action See all actions
Senate • Mar 12, 2026: First Reading
Latest Bill Text See all bill texts
Engrossed

Summary

Comments on HB 3834

Tweets

Whip Lists

Sponsors
Votes
Feb 11, 2026, House
DO PASS
YES: 5
NO: 0
OTHER: 0
YES: 5

NO: 0

    OTHER: 0
    Sources
    Feb 19, 2026, House
    DO PASS
    YES: 10
    NO: 0
    OTHER: 0
    YES: 10

    NO: 0

      OTHER: 0
      Sources
      Mar 11, 2026, House
      THIRD READING
      YES: 68
      NO: 23
      OTHER: 8
      YES: 68

      NO: 23

      EXCUSED: 8

      Sources
      Actions
      • Mar 12, 2026 | Senate
        • First Reading
      • Mar 12, 2026 | House
        • Engrossed, signed, to Senate
      • Mar 11, 2026 | House
        • General Order
        • Amended
        • Third Reading, Measure passed: Ayes: 68 Nays: 23
        • Referred for engrossment
      • Feb 19, 2026 | House
        • CR; Do Pass Health and Human Services Oversight Committee
      • Feb 11, 2026 | House
        • Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health
        • Coauthored by Representative(s) Pae
        • Authored by Senator Frix (principal Senate author)
      • Feb 03, 2026 | House
        • Second Reading referred to Health and Human Services Oversight
        • Referred to Public Health
      • Feb 02, 2026 | House
        • First Reading
        • Authored by Representative May
      Bill Texts
      Documents
      Sources